<?xml version="1.0" encoding="UTF-8" ?><!DOCTYPE dokumente SYSTEM "http://www.gesetze-im-internet.de/dtd/1.01/gii-norm.dtd">
<dokumente builddate="20160801215018" doknr="BJNR162410016"><norm builddate="20160801215018" doknr="BJNR162410016"><metadaten><jurabk>DmMV 2016</jurabk><amtabk>DmMV</amtabk><ausfertigung-datum manuell="ja">2016-07-08</ausfertigung-datum><fundstelle typ="amtlich"><periodikum>BGBl I</periodikum><zitstelle>2016, 1624</zitstelle></fundstelle><kurzue>Dopingmittel-Mengen-Verordnung</kurzue><langue>Verordnung zur Festlegung der nicht geringen Menge von Dopingmitteln</langue></metadaten><textdaten><fussnoten><Content><P><BR/> <pre xml:space="preserve">(+++ Textnachweis ab: 15.7.2016 +++)<BR/><BR/></pre>Die V wurde als Artikel 2 der V v. 8.7.2016 I 1624 vom Bundesministerium für Gesundheit im Einvernehmen mit dem Bundesministerium des Innern nach Anhörung von Sachverständigen mit Zustimmung des Bundesrates beschlossen. Sie ist gem. Art. 3 Satz 1 dieser V am 15.7.2016 in Kraft getreten.</P></Content></fussnoten></textdaten></norm>
<norm builddate="20160801215018" doknr="BJNR162410016BJNE000100000"><metadaten><jurabk>DmMV 2016</jurabk><jurabk>DmMV</jurabk><enbez>(XXXX)</enbez></metadaten><textdaten><text format="XML"><Content><P>Die nicht geringe Menge der Stoffe im Sinne des § 2 Absatz 3 des Anti-Doping-Gesetzes ist die in der Anlage bestimmte Menge. Die nicht geringe Menge wird für die freie Verbindung des betreffenden Stoffes angegeben.</P></Content></text></textdaten></norm>
<norm builddate="20160801215018" doknr="BJNR162410016BJNE000200000"><metadaten><jurabk>DmMV 2016</jurabk><jurabk>DmMV</jurabk><enbez>Anlage</enbez></metadaten><textdaten><text format="XML"><Content><P><noindex><kommentar typ="Fundstelle">(Fundstelle: BGBl. I 2016, 1625 - 1628)</kommentar></noindex></P><BR/><P><DL Font="normal" Indent="5.5" Type="Roman"><DT><B>I)</B></DT><DD Font="bold"><LA Size="normal"><B><SP>Anabole Stoffe</SP></B><DL Font="normal" Type="arabic"><DT><B>1.</B></DT><DD Font="bold"><LA Size="normal"><B>Anabol-androgene Steroide</B><DL Font="normal" Type="alpha"><DT>a)</DT><DD Font="normal"><LA Size="normal">Exogene anabol-androgene Steroide <table colsep="1" frame="all" pgwide="1" rowsep="1" tocentry="%yes;"><tgroup align="left" char="" charoff="50" cols="2"><colspec colname="col1" colnum="1" colwidth="80*"/><colspec align="right" colname="col2" colnum="2" colwidth="20*"/><thead valign="bottom"><row><entry VJ="1" colname="col1"/><entry VJ="1" colname="col2">nicht geringe Menge</entry></row></thead><tbody valign="top"><row><entry VJ="1" colname="col1">1-Androstendiol</entry><entry VJ="1" align="right" colname="col2">3 000 mg</entry></row><row><entry VJ="1" colname="col1">1-Androstendion</entry><entry VJ="1" colname="col2">3 000 mg</entry></row><row><entry VJ="1" colname="col1">Bolandiol</entry><entry VJ="1" colname="col2">3 000 mg</entry></row><row><entry VJ="1" colname="col1">Bolasteron</entry><entry VJ="1" colname="col2">100 mg</entry></row><row><entry VJ="1" colname="col1">Boldenon</entry><entry VJ="1" colname="col2">1 000 mg</entry></row><row><entry VJ="1" colname="col1">Boldion</entry><entry VJ="1" colname="col2">3 000 mg</entry></row><row><entry VJ="1" colname="col1">Calusteron</entry><entry VJ="1" colname="col2">100 mg</entry></row><row rowsep="0"><entry VJ="1" colname="col1">Clostebol</entry><entry VJ="1" colname="col2"/></row><row rowsep="0"><entry VJ="1" colname="col1">– parenterale Darreichungsformen</entry><entry VJ="1" colname="col2">80 mg</entry></row><row><entry VJ="1" colname="col1">– andere Darreichungsformen</entry><entry VJ="1" colname="col2">900 mg</entry></row><row><entry VJ="1" colname="col1">Danazol</entry><entry VJ="1" colname="col2">3 000 mg</entry></row><row><entry VJ="1" colname="col1">Dehydrochlormethyltestosteron</entry><entry VJ="1" colname="col2">100 mg</entry></row><row><entry VJ="1" colname="col1">Desoxymethyltestosteron</entry><entry VJ="1" colname="col2">100 mg</entry></row><row><entry VJ="1" colname="col1">Drostanolon</entry><entry VJ="1" colname="col2">1 015 mg</entry></row><row><entry VJ="1" colname="col1">Ethylestrenol</entry><entry VJ="1" colname="col2">450 mg</entry></row><row><entry VJ="1" colname="col1">Fluoxymesteron</entry><entry VJ="1" colname="col2">  100 mg</entry></row><row><entry VJ="1" colname="col1">Formebolon</entry><entry VJ="1" colname="col2">  100 mg</entry></row><row><entry VJ="1" colname="col1">Furazabol</entry><entry VJ="1" colname="col2">  100 mg</entry></row><row><entry VJ="1" colname="col1">Gestrinon</entry><entry VJ="1" colname="col2">45 mg</entry></row><row><entry VJ="1" colname="col1">4-Hydroxytestosteron</entry><entry VJ="1" colname="col2">1 500 mg</entry></row><row><entry VJ="1" colname="col1">Mestanolon</entry><entry VJ="1" colname="col2">  100 mg</entry></row><row><entry VJ="1" colname="col1">Mesterolon</entry><entry VJ="1" colname="col2">1 500 mg</entry></row><row><entry VJ="1" colname="col1">Metandienon</entry><entry VJ="1" colname="col2">  100 mg</entry></row><row rowsep="0"><entry VJ="1" colname="col1">Metenolon</entry><entry VJ="1" colname="col2"/></row><row rowsep="0"><entry VJ="1" colname="col1">– parenterale Darreichungsformen</entry><entry VJ="1" colname="col2">  150 mg</entry></row><row><entry VJ="1" colname="col1">– andere Darreichungsformen</entry><entry VJ="1" colname="col2">1 500 mg</entry></row><row><entry VJ="1" colname="col1">Methandriol</entry><entry VJ="1" colname="col2">100 mg</entry></row><row><entry VJ="1" colname="col1">Methasteron</entry><entry VJ="1" colname="col2">100 mg</entry></row><row><entry VJ="1" colname="col1">Methyldienolon</entry><entry VJ="1" colname="col2">45 mg</entry></row><row><entry VJ="1" colname="col1">Methyl-1-testosteron</entry><entry VJ="1" colname="col2">100 mg</entry></row><row><entry VJ="1" colname="col1">Methylnortestosteron</entry><entry VJ="1" colname="col2">100 mg</entry></row><row><entry VJ="1" colname="col1">Methyltestosteron</entry><entry VJ="1" colname="col2">100 mg</entry></row><row><entry VJ="1" colname="col1">Metribolon, synonym Methyltrienolon</entry><entry VJ="1" colname="col2">45 mg</entry></row><row><entry VJ="1" colname="col1">Miboleron</entry><entry VJ="1" colname="col2">100 mg</entry></row><row><entry VJ="1" colname="col1">Nandrolon</entry><entry VJ="1" colname="col2">45 mg</entry></row><row><entry VJ="1" colname="col1">19-Norandrostendion</entry><entry VJ="1" colname="col2">3 000 mg</entry></row><row><entry VJ="1" colname="col1">Norboleton</entry><entry VJ="1" colname="col2">450 mg</entry></row><row><entry VJ="1" colname="col1">Norclostebol</entry><entry VJ="1" colname="col2">1 500 mg</entry></row><row><entry VJ="1" colname="col1">Norethandrolon</entry><entry VJ="1" colname="col2">450 mg</entry></row><row><entry VJ="1" colname="col1">Oxabolon</entry><entry VJ="1" colname="col2">75 mg</entry></row><row><entry VJ="1" colname="col1">Oxandrolon</entry><entry VJ="1" colname="col2">100 mg</entry></row><row><entry VJ="1" colname="col1">Oxymesteron</entry><entry VJ="1" colname="col2">100 mg</entry></row><row><entry VJ="1" colname="col1">Oxymetholon</entry><entry VJ="1" colname="col2">100 mg</entry></row><row><entry VJ="1" colname="col1">Prostanozol</entry><entry VJ="1" colname="col2">1 500 mg</entry></row><row><entry VJ="1" colname="col1">Quinbolon</entry><entry VJ="1" colname="col2">1 500 mg</entry></row><row><entry VJ="1" colname="col1">Stanozolol</entry><entry VJ="1" colname="col2">100 mg</entry></row><row><entry VJ="1" colname="col1">Stenbolon</entry><entry VJ="1" colname="col2">1 500 mg</entry></row><row><entry VJ="1" colname="col1">1-Testosteron</entry><entry VJ="1" colname="col2">1 500 mg</entry></row><row><entry VJ="1" colname="col1">Tetrahydrogestrinon</entry><entry VJ="1" colname="col2">45 mg</entry></row><row><entry VJ="1" colname="col1">Trenbolon</entry><entry VJ="1" colname="col2">150 mg</entry></row><row rowsep="0"><entry VJ="1" colname="col1">Andere mit anabol-androgenen Steroiden verwandte Stoffe</entry><entry VJ="1" colname="col2"/></row><row rowsep="0"><entry VJ="1" colname="col1">– mit 17alpha-Methyl-Struktur</entry><entry VJ="1" colname="col2">100 mg</entry></row><row><entry VJ="1" colname="col1">– mit anderen Strukturen</entry><entry VJ="1" colname="col2">3 000 mg</entry></row></tbody></tgroup></table></LA></DD><DT>b)</DT><DD Font="normal"><LA Size="normal">Endogene anabol-androgene Steroide <table colsep="1" frame="all" pgwide="1" rowsep="1" tocentry="%yes;"><tgroup align="left" char="" charoff="50" cols="2"><colspec colname="col1" colnum="1" colwidth="80*"/><colspec align="right" colname="col2" colnum="2" colwidth="20*"/><thead valign="bottom"><row><entry VJ="1" colname="col1"/><entry VJ="1" colname="col2">nicht geringe Menge</entry></row></thead><tbody valign="top"><row><entry VJ="1" colname="col1">Androstendiol</entry><entry VJ="1" colname="col2">3 000 mg</entry></row><row><entry VJ="1" colname="col1">Androstendion</entry><entry VJ="1" colname="col2">3 000 mg</entry></row><row><entry VJ="1" colname="col1">Androstanolon, synonym Dihydrotestosteron</entry><entry VJ="1" colname="col2">1 500 mg</entry></row><row rowsep="0"><entry VJ="1" colname="col1">Prasteron, synonym Dehydroepiandrosteron (DHEA)</entry><entry VJ="1" colname="col2"/></row><row rowsep="0"><entry VJ="1" colname="col1">– parenterale Darreichungsformen</entry><entry VJ="1" colname="col2">144 mg</entry></row><row><entry VJ="1" colname="col1">– andere Darreichungsformen</entry><entry VJ="1" colname="col2">3 000 mg</entry></row><row rowsep="0"><entry VJ="1" colname="col1">Testosteron</entry><entry VJ="1" colname="col2"/></row><row rowsep="0"><entry VJ="1" colname="col1">– transdermale oder orale Darreichungsformen</entry><entry VJ="1" colname="col2">1 500 mg</entry></row><row><entry VJ="1" colname="col1">– sonstige Darreichungsformen</entry><entry VJ="1" colname="col2">632 mg</entry></row></tbody></tgroup></table></LA></DD></DL></LA></DD><DT><B>2.</B></DT><DD Font="normal"><LA Size="normal"><B>Andere anabole Stoffe</B><table colsep="1" frame="all" pgwide="1" rowsep="1" tocentry="%yes;"><tgroup align="left" char="" charoff="50" cols="2"><colspec colname="col1" colnum="1" colwidth="80*"/><colspec align="right" colname="col2" colnum="2" colwidth="19.5*"/><thead valign="bottom"><row><entry VJ="1" colname="col1"/><entry VJ="1" colname="col2">nicht geringe Menge</entry></row></thead><tbody valign="top"><row><entry VJ="1" colname="col1">Clenbuterol</entry><entry VJ="1" colname="col2">2,1 mg</entry></row><row><entry VJ="1" colname="col1">Selektive Androgen-Rezeptor-Modulatoren (SARMs)</entry><entry VJ="1" colname="col2">90 mg</entry></row><row><entry VJ="1" colname="col1">Tibolon</entry><entry VJ="1" colname="col2">75 mg</entry></row><row><entry VJ="1" colname="col1">Zeranol</entry><entry VJ="1" colname="col2">4,5 mg</entry></row><row><entry VJ="1" colname="col1">Zilpaterol</entry><entry VJ="1" colname="col2">4,5 mg</entry></row></tbody></tgroup></table></LA></DD></DL></LA></DD><DT><B>II)</B></DT><DD Font="bold"><LA Size="normal"><B><SP>Peptidhormone, Wachstumsfaktoren, verwandte Stoffe und Mimetika</SP></B><DL Font="normal" Type="arabic"><DT><B>1.</B></DT><DD Font="normal"><LA Size="normal"><B>Erythropoese stimulierende Stoffe</B><table colsep="1" frame="all" pgwide="1" rowsep="1" tocentry="%yes;"><tgroup align="left" char="" charoff="50" cols="2"><colspec colname="col1" colnum="1" colwidth="80*"/><colspec align="right" colname="col2" colnum="2" colwidth="19.5*"/><thead valign="bottom"><row><entry VJ="1" colname="col1"/><entry VJ="1" colname="col2">nicht geringe Menge</entry></row></thead><tbody valign="top"><row rowsep="0"><entry VJ="1" colname="col1">Erythropoetin human (EPO)</entry><entry VJ="1" colname="col2">24 000 IE</entry></row><row><entry VJ="1" colname="col1">Epoetin alfa, beta, delta, omega, theta, zeta und analoge rekombinante humane Erythropoetine</entry><entry VJ="1" colname="col2"/></row><row><entry VJ="1" colname="col1">Darbepoetin alfa (dEPO)</entry><entry VJ="1" colname="col2">120 µg</entry></row><row><entry VJ="1" colname="col1">Methoxy-Polyethylenglycol-Epoetin beta, synonym PEG-Epoetin beta, Continuous Erythropoiesis Receptor Activator (CERA)</entry><entry VJ="1" colname="col2">90 µg</entry></row><row><entry VJ="1" colname="col1">Peginesatid, synonym Hematid</entry><entry VJ="1" colname="col2">5 mg</entry></row></tbody></tgroup></table></LA></DD><DT><B>2.</B></DT><DD Font="normal"><LA Size="normal"><B>Choriongonadotropin (CG) und Luteinisierendes Hormon (LH)</B><table colsep="1" frame="all" pgwide="1" rowsep="1" tocentry="%yes;"><tgroup align="left" char="" charoff="50" cols="2"><colspec colname="col1" colnum="1" colwidth="80*"/><colspec align="right" colname="col2" colnum="2" colwidth="19.5*"/><thead valign="bottom"><row><entry VJ="1" colname="col1" valign="top"/><entry VJ="1" colname="col2" valign="top">nicht geringe Menge</entry></row></thead><tbody valign="top"><row><entry VJ="1" colname="col1">Choriongonadotropin (HCG)</entry><entry VJ="1" colname="col2">7 500 IE</entry></row><row><entry VJ="1" colname="col1">Choriogonadotropin alfa</entry><entry VJ="1" colname="col2">250 µg</entry></row><row><entry VJ="1" colname="col1">Lutropin alfa</entry><entry VJ="1" colname="col2">2 250 IE</entry></row></tbody></tgroup></table></LA></DD><DT><B>3.</B></DT><DD Font="normal"><LA Size="normal"><B>Corticotropine</B><table colsep="1" frame="all" pgwide="1" rowsep="1" tocentry="%yes;"><tgroup align="left" char="" charoff="50" cols="2"><colspec colname="col1" colnum="1" colwidth="80*"/><colspec align="right" colname="col2" colnum="2" colwidth="19.5*"/><thead valign="bottom"><row><entry VJ="1" colname="col1"/><entry VJ="1" colname="col2">nicht geringe Menge</entry></row></thead><tbody valign="top"><row><entry VJ="1" colname="col1">Corticotropin</entry><entry VJ="1" colname="col2">1 200 IE</entry></row><row rowsep="0"><entry VJ="1" colname="col1">Tetracosactid</entry><entry VJ="1" colname="col2"/></row><row rowsep="0"><entry VJ="1" colname="col1">– retardierte parenterale Darreichungsformen</entry><entry VJ="1" colname="col2">12 mg</entry></row><row><entry VJ="1" colname="col1">– sonstige parenterale Darreichungsformen</entry><entry VJ="1" colname="col2">3 mg</entry></row></tbody></tgroup></table></LA></DD><DT><B>4.</B></DT><DD Font="normal"><LA Size="normal"><B>Wachstumshormon, Releasingfaktoren, Releasingpeptide und Wachstumsfaktoren</B><table colsep="1" frame="all" pgwide="1" rowsep="1" tocentry="%yes;"><tgroup align="left" char="" charoff="50" cols="2"><colspec colname="col1" colnum="1" colwidth="80*"/><colspec align="right" colname="col2" colnum="2" colwidth="19.5*"/><thead valign="bottom"><row><entry VJ="1" colname="col1"/><entry VJ="1" colname="col2">nicht geringe Menge</entry></row></thead><tbody valign="top"><row><entry VJ="1" colname="col1">Somatropin, synonym Wachstumshormon human, Growth Hormone (GH)</entry><entry VJ="1" colname="col2">16 mg</entry></row><row><entry VJ="1" colname="col1">Somatrem, synonym Somatotropin (methionyl), human</entry><entry VJ="1" colname="col2">16 mg</entry></row><row rowsep="0"><entry VJ="1" colname="col1">Wachstumshormon Releasingfaktoren, synonym Growth Hormone Releasing Hormones (GHRH)</entry><entry VJ="1" colname="col2">1,5 mg</entry></row><row rowsep="0"><entry VJ="1" colname="col1">Sermorelin</entry><entry VJ="1" colname="col2"/></row><row rowsep="0"><entry VJ="1" colname="col1">Somatorelin</entry><entry VJ="1" colname="col2"/></row><row><entry VJ="1" colname="col1">und Peptide mit gleicher Wirkung, synonym Growth Hormone Releasing Peptides (GHRP)</entry><entry VJ="1" colname="col2"/></row><row><entry VJ="1" colname="col1">Mecasermin, synonym Insulin-ähnlicher Wachstumsfaktor 1,<BR/> Insulin-like Growth Factor -1 (IGF-1)</entry><entry VJ="1" colname="col2">60 mg</entry></row><row><entry VJ="1" colname="col1">IGF-1 Analoga</entry><entry VJ="1" colname="col2">3 mg</entry></row></tbody></tgroup></table></LA></DD></DL></LA></DD><DT><B>III)</B></DT><DD Font="bold"><LA Size="normal"><B><SP>Hormone und Stoffwechsel-Modulatoren</SP></B><DL Font="normal" Type="arabic"><DT><B>1.</B></DT><DD Font="normal"><LA Size="normal"><B>Aromatasehemmer</B><table colsep="1" frame="all" pgwide="1" rowsep="1" tocentry="%yes;"><tgroup align="left" char="" charoff="50" cols="2"><colspec colname="col1" colnum="1" colwidth="80*"/><colspec align="right" colname="col2" colnum="2" colwidth="19.5*"/><thead valign="bottom"><row><entry VJ="1" colname="col1"/><entry VJ="1" colname="col2">nicht geringe Menge</entry></row></thead><tbody valign="top"><row><entry VJ="1" colname="col1">Aminoglutethimid</entry><entry VJ="1" colname="col2">30 000 mg</entry></row><row><entry VJ="1" colname="col1">Anastrozol</entry><entry VJ="1" colname="col2">30 mg</entry></row><row><entry VJ="1" colname="col1">Androsta-1,4,6-trien-3,17-dion, synonym Androstatriendion</entry><entry VJ="1" colname="col2"> 3 000 mg</entry></row><row><entry VJ="1" colname="col1">4-Androsten-3,6,17-trion (6-oxo)</entry><entry VJ="1" colname="col2"> 6 000 mg</entry></row><row><entry VJ="1" colname="col1">Exemestan</entry><entry VJ="1" colname="col2">750 mg</entry></row><row><entry VJ="1" colname="col1">Formestan</entry><entry VJ="1" colname="col2">600 mg</entry></row><row><entry VJ="1" colname="col1">Letrozol</entry><entry VJ="1" colname="col2">75 mg</entry></row><row><entry VJ="1" colname="col1">Testolacton</entry><entry VJ="1" colname="col2">6 000 mg</entry></row></tbody></tgroup></table></LA></DD><DT><B>2.</B></DT><DD Font="normal"><LA Size="normal"><B>Selektive Estrogen-Rezeptor-Modulatoren (SERMs)</B><table colsep="1" frame="all" pgwide="1" rowsep="1" tocentry="%yes;"><tgroup align="left" char="" charoff="50" cols="2"><colspec colname="col1" colnum="1" colwidth="80*"/><colspec align="right" colname="col2" colnum="2" colwidth="19.5*"/><thead valign="bottom"><row><entry VJ="1" colname="col1"/><entry VJ="1" colname="col2">nicht geringe Menge</entry></row></thead><tbody valign="top"><row><entry VJ="1" colname="col1">Raloxifen</entry><entry VJ="1" colname="col2">1 680 mg</entry></row><row><entry VJ="1" colname="col1">Tamoxifen</entry><entry VJ="1" colname="col2">  600 mg</entry></row><row><entry VJ="1" colname="col1">Toremifen</entry><entry VJ="1" colname="col2">1 800 mg</entry></row></tbody></tgroup></table></LA></DD><DT><B>3.</B></DT><DD Font="normal"><LA Size="normal"><B>Andere antiestrogen wirkende Stoffe</B><table colsep="1" frame="all" pgwide="1" rowsep="1" tocentry="%yes;"><tgroup align="left" char="" charoff="50" cols="2"><colspec colname="col1" colnum="1" colwidth="80*"/><colspec align="right" colname="col2" colnum="2" colwidth="19.5*"/><thead valign="bottom"><row><entry VJ="1" colname="col1"/><entry VJ="1" colname="col2">nicht geringe Menge</entry></row></thead><tbody valign="top"><row><entry VJ="1" colname="col1">Clomifen</entry><entry VJ="1" colname="col2">509 mg</entry></row><row><entry VJ="1" colname="col1">Cyclofenil</entry><entry VJ="1" colname="col2">4 200 mg</entry></row><row><entry VJ="1" colname="col1">Fulvestrant</entry><entry VJ="1" colname="col2">250 mg</entry></row></tbody></tgroup></table></LA></DD><DT><B>4.</B></DT><DD Font="normal"><LA Size="normal"><B>Myostatinfunktionen verändernde Stoffe</B></LA><LA Size="normal">Myostatinhemmer <table colsep="1" frame="all" pgwide="1" rowsep="1" tocentry="%yes;"><tgroup align="left" char="" charoff="50" cols="2"><colspec colname="col1" colnum="1" colwidth="80*"/><colspec align="right" colname="col2" colnum="2" colwidth="19.5*"/><thead valign="bottom"><row><entry VJ="1" colname="col1"/><entry VJ="1" colname="col2">nicht geringe Menge</entry></row></thead><tbody valign="top"><row><entry VJ="1" colname="col1">Stamulumab</entry><entry VJ="1" colname="col2">450 mg</entry></row></tbody></tgroup></table></LA></DD><DT><B>5.</B></DT><DD Font="normal"><LA Size="normal"><B>Stoffwechsel-Modulatoren</B><table colsep="1" frame="all" pgwide="1" rowsep="1" tocentry="%yes;"><tgroup align="left" char="" charoff="50" cols="2"><colspec colname="col1" colnum="1" colwidth="80*"/><colspec align="right" colname="col2" colnum="2" colwidth="19.5*"/><thead valign="bottom"><row><entry VJ="1" colname="col1" valign="top"/><entry VJ="1" colname="col2" valign="top">nicht geringe Menge</entry></row></thead><tbody valign="top"><row><entry VJ="1" colname="col1">Insuline</entry><entry VJ="1" colname="col2">400 IE</entry></row><row rowsep="0"><entry VJ="1" colname="col1">PPAR<F>δ</F> (Peroxisome Proliferator Activated Receptor Delta)-Agonisten, synonym PPAR-delta-Agonisten</entry><entry VJ="1" colname="col2">  75 mg</entry></row><row><entry VJ="1" colname="col1">GW 501516, synonym GW 1516</entry><entry VJ="1" colname="col2"/></row><row rowsep="0"><entry VJ="1" colname="col1">AMPK (PPAR<F>δ–AMP-activated protein kinase)-Axis-Agonisten</F></entry><entry VJ="1" colname="col2">7 000 mg</entry></row><row><entry VJ="1" colname="col1">AICAR</entry><entry VJ="1" colname="col2"/></row><row><entry VJ="1" colname="col1">Meldonium</entry><entry VJ="1" colname="col2">15 000 mg</entry></row></tbody></tgroup></table></LA></DD></DL></LA></DD></DL></P></Content></text></textdaten></norm>
</dokumente>